ES2080044T3 - Moleculas de adhesion intercelular y sus ligandos de fijacion. - Google Patents

Moleculas de adhesion intercelular y sus ligandos de fijacion.

Info

Publication number
ES2080044T3
ES2080044T3 ES88106901T ES88106901T ES2080044T3 ES 2080044 T3 ES2080044 T3 ES 2080044T3 ES 88106901 T ES88106901 T ES 88106901T ES 88106901 T ES88106901 T ES 88106901T ES 2080044 T3 ES2080044 T3 ES 2080044T3
Authority
ES
Spain
Prior art keywords
adhesion molecules
intercellular adhesion
join
fixation links
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88106901T
Other languages
English (en)
Inventor
Timothy Alan Springer
Robert Rothlein
Steven Dean Marlin
Michael Loran Dustin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Application granted granted Critical
Publication of ES2080044T3 publication Critical patent/ES2080044T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A MOLECULAS DE ADHESION INTERCELULAR IMPLICADAS EN EL PROCESO A TRAVES DEL CUAL LOS LINFOCITOS RECONOCEN Y EMIGRAN A AUS SITIOS DE INFLAMACION Y SE UNEN A SUSTRATOS CELULARES DURANTE LA INFLAMACION. LA INVENCION SE REFIERE A DICHAS MOLECULAS, A ENSAYOS PARA SU IDENTIFICACION Y A ANTICUERPOS CAPACES DE UNIRSE A ELLAS. LA INVENCION INCLUYE TAMBIEN EMPLEOS PARA LAS MOLECULAS DE ADHESION Y PARA ANTICUERPOS QUE SON CAPACES DE UNIRSE A ELLAS.
ES88106901T 1987-05-04 1988-04-29 Moleculas de adhesion intercelular y sus ligandos de fijacion. Expired - Lifetime ES2080044T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4596387A 1987-05-04 1987-05-04
US11579887A 1987-11-02 1987-11-02
US15594388A 1988-02-16 1988-02-16

Publications (1)

Publication Number Publication Date
ES2080044T3 true ES2080044T3 (es) 1996-02-01

Family

ID=27366801

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88106901T Expired - Lifetime ES2080044T3 (es) 1987-05-04 1988-04-29 Moleculas de adhesion intercelular y sus ligandos de fijacion.

Country Status (15)

Country Link
EP (1) EP0289949B1 (es)
JP (2) JP2763030B2 (es)
AT (1) ATE128727T1 (es)
AU (1) AU1551888A (es)
CA (1) CA1341399C (es)
DE (1) DE3854536T2 (es)
DK (1) DK174629B1 (es)
ES (1) ES2080044T3 (es)
FI (1) FI882037A7 (es)
GR (1) GR3018298T3 (es)
IE (1) IE69976B1 (es)
IL (1) IL86246A (es)
MX (1) MX9203033A (es)
NZ (2) NZ224490A (es)
PT (1) PT87390B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
ATE114972T1 (de) * 1987-11-02 1994-12-15 Baylor College Medicine Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen.
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
US6218525B1 (en) 1988-02-25 2001-04-17 The General Hospital Corporation Nucleic acid encoding CD28
EP0429542B1 (en) * 1988-08-15 1995-12-06 Brigham And Women's Hospital Leukocyte adhesion inhibitor
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
EP0362531B1 (en) 1988-09-01 1999-11-10 Bayer Corporation A human rhinovirus receptor protein that inhibits virus infectivity
KR900701846A (ko) * 1988-09-28 1990-12-04 원본미기재 세포간 점착분자 및 이의 결합 리간드
ES2077572T3 (es) * 1988-09-28 1995-12-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular, y sus ligandos de fijacion.
US5081034A (en) * 1988-11-14 1992-01-14 Brigham & Women's Hospital Cloned genes which encode elam-1
CA2008368C (en) * 1989-01-24 2003-04-08 Jeffrey Greve Soluble molecule related to but distinct from icam-1
NO900155L (no) * 1989-01-24 1990-07-25 Molecular Therapeutics Inc Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1.
US5235049A (en) * 1989-01-24 1993-08-10 Molecular Therapeutics, Inc. Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
US5776775A (en) * 1989-02-21 1998-07-07 Dana-Farber Cancer Institute Anti-LAM 1-3 antibody and hybridoma
ES2035668T3 (es) * 1989-03-09 1993-04-16 Boehringer Ingelheim Pharmaceuticals Inc. Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
ES2097747T3 (es) * 1989-03-09 1997-04-16 Blood Res Center Molecula de adhesion intercelular 2 y sus ligandos de union.
US6797270B1 (en) 1989-03-16 2004-09-28 Center For Blood Research, Inc. Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
DK0745852T3 (da) * 1989-03-16 2002-10-14 Blood Res Center Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
AU5553290A (en) * 1989-04-28 1990-11-29 Baylor College Of Medicine Dissemination of hiv-1 infected cells
WO1990013281A2 (en) * 1989-04-28 1990-11-15 Baylor College Of Medicine Method of suppressing hiv infection
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
WO1991018011A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
ATE184049T1 (de) * 1990-07-20 1999-09-15 Bayer Ag Multimere formen des menschlichen rhinovirus- rezeptorproteins
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US5223396A (en) * 1991-05-03 1993-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Method for detecting organ transplant rejection
US5629162A (en) * 1991-06-11 1997-05-13 The Center For Blood Research Method of identifying agents which modulate ICAM-3 binding to LFA-1
AU2777092A (en) * 1991-10-04 1993-05-03 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Treatment of ocular inflammation by blockage of cell adhesion molecules
US5837822A (en) * 1992-01-27 1998-11-17 Icos Corporation Humanized antibodies specific for ICAM related protein
US5811517A (en) * 1992-01-27 1998-09-22 Icos Corporation ICAM-related protein variants
US5700658A (en) * 1992-01-27 1997-12-23 Icos Corporation ICAM-4 materials and methods
US6818743B1 (en) 1992-01-27 2004-11-16 Icos Corporation I-CAM related protein
US6100383A (en) * 1992-01-27 2000-08-08 Icos Corporation Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
US5532127A (en) * 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
US5702917A (en) * 1992-01-27 1997-12-30 Icos Corporation Polynucleotides encoding human ICAM-4
US5989843A (en) * 1992-01-27 1999-11-23 Icos Corporation Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein
US6153395A (en) * 1992-01-27 2000-11-28 Icos Corporation ICAM-related protein
US5525487A (en) * 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
EP0578819A4 (en) * 1992-01-27 1994-10-12 Icos Corp Icam-related protein.
US5708141A (en) * 1992-05-11 1998-01-13 Corvas International, Inc. Neutrophil inhibitors
US5580780A (en) * 1992-06-09 1996-12-03 Jalkanen; Sirpa Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies
US5602307A (en) * 1992-08-12 1997-02-11 Baylor College Of Medicine Non-human animal having predefined allele of a cellular adhesion gene
CA2140933A1 (en) * 1992-08-21 1994-02-22 Paula M. Jardieu Method for treating an lfa-1 mediated disorder
AU5675794A (en) * 1992-12-15 1994-07-04 Board Of Trustees Of The Leland Stanford Junior University Mucosal vascular addressin, dna and expression
DE4335273A1 (de) * 1993-10-15 1995-04-20 Univ Ludwigs Albert Peptide zur Tumortherapie
CA2187360A1 (en) * 1994-04-12 1995-10-19 Craig D. Wegner Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
ATE310536T1 (de) * 1998-08-04 2005-12-15 Univ Pennsylvania Zielrichtung und verlängerte assoziation von wirkstoffen an die luminale oberfläche der pulmonaren vaskularen endothelzellen
US20030035798A1 (en) 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
US6582698B1 (en) 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
WO2000056363A1 (en) 1999-03-19 2000-09-28 Genentech, Inc. Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
US7674466B2 (en) 1999-08-05 2010-03-09 The Trustees Of The University Of Pennsylvania Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells using antibodies that bind to ICAM-1
AU2001230920A1 (en) * 2000-01-14 2001-07-24 Genentech Inc. Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
JP2005522192A (ja) 2001-07-19 2005-07-28 パーラン セラピューティクス， インコーポレイテッド マルチマータンパク質およびマルチマータンパク質を作製および使用する方法
PT2382474E (pt) 2009-01-20 2015-06-03 Transgene Sa Icam-1 solúvel como biomarcador para a previsão de uma resposta terapêutica
AU2012211519B2 (en) * 2011-02-02 2015-07-30 Medipost Co., Ltd. Use of ICAM-1 for prevention or treatment of neurological diseases

Also Published As

Publication number Publication date
JPH01110700A (ja) 1989-04-27
IE69976B1 (en) 1996-10-16
DK174629B1 (da) 2003-07-28
GR3018298T3 (en) 1996-03-31
DK239488D0 (da) 1988-05-03
FI882037A7 (fi) 1988-11-05
JP2763030B2 (ja) 1998-06-11
FI882037A0 (fi) 1988-05-02
JPH10101699A (ja) 1998-04-21
AU1551888A (en) 1988-11-10
MX9203033A (es) 1992-07-01
EP0289949A2 (en) 1988-11-09
HK1003117A1 (en) 1998-10-09
DK239488A (da) 1988-11-05
NZ237036A (en) 1997-09-22
PT87390B (pt) 1993-11-30
ATE128727T1 (de) 1995-10-15
JP2874861B2 (ja) 1999-03-24
EP0289949A3 (en) 1990-09-26
IL86246A0 (en) 1988-11-15
EP0289949B1 (en) 1995-10-04
DE3854536D1 (de) 1995-11-09
IL86246A (en) 1994-06-24
DE3854536T2 (de) 1996-03-07
CA1341399C (en) 2002-11-19
NZ224490A (en) 1991-11-26
IE881322L (en) 1988-11-04
PT87390A (pt) 1989-05-31

Similar Documents

Publication Publication Date Title
MX9203033A (es) Moleculas de adherencia intercelular y sus ligados de fijacion.
ES2097747T3 (es) Molecula de adhesion intercelular 2 y sus ligandos de union.
ES2077572T3 (es) Moleculas de adhesion intercelular, y sus ligandos de fijacion.
AT297631B (de) Verfahren und Vorrichtung für die Verbindung von Rohrelementen mit zussammenpassenden, mit Gewinde versehenen Enden
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
SE7514049L (sv) Sett att generera en ph-funktion for anvendning vid separation
ES2031237T3 (es) Metodo y aparato para ligar dinamicamente por medios mecanicos.
AR000905A1 (es) Elemento auxiliar para la osteosintesis
RO86320A (ro) Procedeu de preparare a unor derivati de 1,284-triazina si pirazina
ATE37102T1 (de) Vorrichtung zum ausrichten optischer bestandteile.
MX9304580A (es) Proteina de tirosina-fosfatasa del tipo receptor de mamifero, molecula de adn que la codifica y proceso para su preparacion.
CH552420A (de) Verfahren fuer einseitiges nieten mittels hohlnieten und nietgeraet zur durchfuehrung dieses verfahrens.
ES2032052T3 (es) Procedimiento para la obtencion de n,n-(dibenzohexatrienilen) ureas.
ES2022865B3 (es) Compuestos azoicos que contienen grupos ciano, procedimientos para su obtencion y aplicacion de los mismos como colorantes.
DE50301617D1 (de) Abstütz- bzw. Abstreifeinrichtung für Siebbandanlagen
SE8003719L (sv) Spennorgan for vulkpress
ATA151877A (de) Verbindungs-, insbesondere haftver- mittlerschicht und verfahren zu deren her- stellung
ES270986Y (es) Util tensor para marcos.
ES2063017T3 (es) Anticuerpos monoclonales para antraciclinas.
BR7800477A (pt) Processo aperfeicoado de radio ensaio simultaneo para folato e vitamina b12
ATA206280A (de) Vorrichtung zur verbindung der kettenglieder von gleisketten an gleichkettenfahrzeugen
BE755129A (fr) Procede de fixation rapide de plafonds
BR7804010A (pt) Elo de uniao para correias
ES179201U (es) Empalme para tendones de armaduras de construccion.
ES1003917Y (es) Util para extraer pasadores que relacionan eslabones de cadena de rodadura de vehiculos blindados y para posicionar los respectivos silentblocks.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 289949

Country of ref document: ES